California

Gov. Gavin Newsom (D) appointed Jacey Cooper to serve as the state Medicaid Director and Chief Deputy Director of Health Care Programs at the Department of Health Care Services. Cooper has been Assistant Deputy Director of Health Care Delivery Systems at the Department of Health Care Services since 2016.  

Also in California... Earlier this month, Gov. Gavin Newsom (D) signed into law several bills adding or amending laws that govern the practice of pharmacy in California. Unless specified otherwise, the new laws took effect on January 1, 2020. Many of the key provisions are summarized below. 

  • AB 528 Controlled Substances: CURES Database Effective January 1, 2021, this law expands the CURES reporting requirements to include Schedule V drugs and reduces the reporting deadline to one working day from the date the prescription was released to the patient. 
  • AB 690 Pharmacies: Relocation: Remote Dispensing Site Pharmacy: Pharmacy Technician: QualificationsEffective upon signing by the Governor, this law creates a limited exemption to the licensure transferability requirements for a pharmacy to relocate because of damage caused by a declared disaster. The law also establishes specific requirements for a pharmacy technician working in a remote dispensing site pharmacy. 
  • AB 973 Pharmacies: Compounding. This law requires that compounding of drug preparations by a pharmacy must be done consistent with the relevant compounding chapters of the United States Pharmacopeia-National Formulary (USP). The board recently released a policy statement regarding California legal requirements for compounding pharmacies pending information from USP regarding implementation of chapters 795, 797, and 800. The policy statement is available on the board’s website. 
  • AB 1723 Clinics: Purchasing Drugs at WholesaleThis law increases the maximum hours of operation for a primary care community clinic or free clinic from 20 hours to 40 hours per week. 
  • SB 159 HIV Preexposure and Postexposure ProphylaxisThis comprehensive law authorizes pharmacists to independently initiate and furnish HIV preexposure and postexposure prophylaxis under specific conditions. Key provisions also require the Board of Pharmacy, in consultation with the Medical Board of California (MBC), to approve training programs that pharmacists must complete before furnishing either preexposure or postexposure prophylaxis. In addition, the law specifies guidelines issued by the federal Centers for Disease Control and Prevention (CDC) that the Board of Pharmacy must use to establish the drug or drug combinations to be furnished: 

The law also requires the Board of Pharmacy to consult with the medical Board in developing emergency regulations to be adopted by July 1, 2020, to implement the law. The board’s Licensing Committee held a meeting in early January with stakeholders regarding implementation of SB 159, and the committee will report its recommendations at the January 29-30 board meeting in Glendale. 

  • SB 569 Controlled Substances: Prescriptions: Declared Local, State, or Federal Emergency. This law authorizes a pharmacist to fill a prescription for a controlled substance that does not conform to the controlled substances security form requirements under specific conditions.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-01-23T09:22:08-05:00January 23, 2020|California|

New Mexico

Pharmacy Day at the Capitol is Monday, January 27. 

Also in New Mexico... NACDS co-signed a letter to Gov. Michelle Grisham Lujan (D) in support HB 42, the bill requiring payment for any pharmacy patient services sponsored by Chair of the House Health and Human Services Committee, Rep. Deborah Armstrong. Other national organizations cosigning the letter were the National Community Pharmacists Association (NCPA), the American Pharmacists Association (APhA), the American Society of Health-System Pharmacists (ASHP), and the National Alliance of State Pharmacy Association (NASPA). 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-01-23T09:20:12-05:00January 23, 2020|New Mexico|

California

In advance of the Board of Pharmacy’s Licensing Committee meeting January 9thNACDS submitted a comment letter providing suggestions for a training program for pharmacist furnishing pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP). 

Also in California… legislative session convened on January 6th.   

Also in California... Gov. Gavin Newsom’s (D) budget released last week proposes $107.4 billion in total funds for Department of Health Care Services programs and other spending.  It includes significant funding for the Medi-Cal Healthier California for All initiative (formerly known as CalAIM); funding to support quality improvements in county-operated behavioral health systems; expanded Medi-Cal coverage for adults age 65 and older, regardless of their documentation status; and funding for efforts to control costs and create incentives for better quality care. For more details, please refer to the links posted on the DHCS website. 

Also in California... The Department of Health Care Services is renaming its multi-year reform initiative aimed at improving the health outcomes and quality of life for California’s population in Medi-Cal. Effective immediately, the broad-based effort to transform the Medi-Cal delivery system, program and payment structure will be known as Medi-Cal Healthier California for All. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-01-16T10:12:20-05:00January 16, 2020|California|

Colorado

HB19-1216 limits the cost sharing of insulin for commercial pay patients to $100 for a 30 days’ supply, effective January1, 2020. The Department of Regulatory Agencies Division of Insurance issued emergency rules to address implementation. https://gallery.mailchimp.com/6431ea4066ae863439c487bd4/files/bd896d11-f54b-4f15-b31d-fd2c3ccad71d/Emergency_Regulation_19_E_08_Concerning_Prescription_Insulin_Drug_Cost_Sharing_and_Limitations.pdf 

Also in Colorado… General Assembly convened on January 8th.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-01-16T10:10:51-05:00January 16, 2020|Colorado|

Florida

Florida House Bill 389 Testing for and Treatment of Influenza and Streptococcus was heard on January 15th in the House Health Care Appropriation Subcommittee. The bill passed favorably with a vote of 10-1. The next stop is the House Health and Human Services.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2020-01-16T10:08:17-05:00January 16, 2020|Florida|

Kentucky

Gov. Andy Beshear (D) has appointed Lisa Lee to serve as the new commissioner of Department for Medicaid Services.  Previously Lee served in the Cabinet for Health and Family Services.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2020-01-16T09:46:59-05:00January 16, 2020|Kentucky|

Louisiana

The Board of Pharmacy is holding a Regulation Revision Committee meeting at 8:30 AM on January 22, 2020. Issues of interest to NACDS members include proposed rules on PBMs, technician ratios, and the Board’s 2020 legislation. To review the agenda, go to – https://protect-us.mimecast.com/s/6FTCCrkBDZfEykwF422Ak?domain=pharmacy.la.gov 

Also in Louisiana... Louisiana Department of Health Secretary Barbara Gee renewed the annual Standing Order for distribution or dispensing of Naloxone and other opioid antagonists effective 1/1/2020. 

Also in Louisiana... Gov. John Bel Edwards (D) appointed Dr Sajal K. Roy, a pharmacist from Madisonville, to serve a six-year term on the Board of Pharmacy, replacing Diane Milano. 

Also in Louisiana... In advance of the December 27th public hearing, NACDS provided the Board of Pharmacy with comments and recommendations on several proposed rules on immunizations and dispensing prescription refills. 

Also in Louisiana... On January 3rd, Louisiana Health Department (LDH) Secretary Rebekah Gee, MD, MPH, submitted her resignation to Gov. John Bel Edwards (D).  Medicaid Director Jen Steele has also resigned from LDH. 

Also in Louisiana... Effective for dates of service on or after August 1, 2019, Medicaid will require all professional service and independent laboratory providers to include a valid CLIA number on all claims submitted for laboratory services, including CLIA waived tests. Claims submitted with an absent, incorrect or invalid CLIA number will deny. For more information go to – http://ldh.la.gov/assets/docs/BayouHealth/Informational_Bulletins/2019/IB19-8/IB19-8_revised_1.3.20.pdf

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-01-16T09:43:33-05:00January 16, 2020|Louisiana|

Oklahoma

law mandating electronic prescribing of all controlled substances which NACDS supported in 2018 went into effect on January 1, 2020. The Board of Pharmacy announced that they have responsibility for the enforcement, application, and interpretation of this statute and have determined that the terms “specified dose” and “different dosage” do not apply to the specific quantity dispensed pursuant to a Schedule II opioid prescription. In order to dispense a lesser than prescribed quantity, a new prescription is not required. (HB 2931-2018)

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2020-01-16T09:41:02-05:00January 16, 2020|Oklahoma|

West Virginia

Legislation requiring prescriptions to be prescribed electronically has been introduced by Del. Geoffrey Foster (R) and referred to the House Committee on Judiciary.  NACDS will work with members and in-state partners to advance the legislation.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2020-01-16T09:38:49-05:00January 16, 2020|West Virginia|
Go to Top